Compare SERA & EPM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SERA | EPM |
|---|---|---|
| Founded | 2008 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Precision Instruments | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 77.2M | 158.2M |
| IPO Year | 2021 | 1996 |
| Metric | SERA | EPM |
|---|---|---|
| Price | $1.83 | $4.69 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $4.93 |
| AVG Volume (30 Days) | 22.8K | ★ 412.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 10.46% |
| EPS Growth | ★ 14.66 | N/A |
| EPS | N/A | ★ 0.05 |
| Revenue | $77,000.00 | ★ $43,229,621.00 |
| Revenue This Year | $25.84 | N/A |
| Revenue Next Year | $715.79 | N/A |
| P/E Ratio | ★ N/A | $92.00 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.37 | $3.19 |
| 52 Week High | $4.34 | $5.70 |
| Indicator | SERA | EPM |
|---|---|---|
| Relative Strength Index (RSI) | 20.26 | 68.52 |
| Support Level | $1.37 | $4.38 |
| Resistance Level | $2.00 | $5.13 |
| Average True Range (ATR) | 0.20 | 0.17 |
| MACD | -0.03 | 0.01 |
| Stochastic Oscillator | 3.63 | 81.08 |
Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.
Evolution Petroleum Corp is an independent energy company focused on owning and investing in onshore oil and natural gas properties across the United States. Its portfolio includes non-operated interests in various production fields such as CO2 enhanced oil recovery in Louisiana, secondary recovery production in Wyoming, and shale gas reservoirs in Texas and North Dakota. The company generates revenue from the production and sale of oil and natural gas, leveraging specialized technologies to extend reservoir life and enhance recoveries.